RRML - The EAS-EFLM consensus on the evaluation of atherogenic lipoproteins in the management of dyslipidemia: A synthesis of the recommendations

Main page
News
RJLabM Credits
Archive
- Current issue
- Ahead of print
- List of published issues
- 2025
  - Nr.1/2025
  - Nr.2/2025
- 2024
  - Nr.4/2024
  - Nr.3/2024
  - Nr.2/2024
  - Nr.1/2024
  - Supplement 1/2024
- 2023
  - Nr.4/2023
  - Nr.3/2023
  - Nr.2/2023
  - Nr.1/2023
  - Supplement 1/2023
- 2022
  - Nr.4/2022
  - Nr.3/2022
  - Nr.2/2022
  - Nr.1/2022
  - Supplement 1/2022
- 2021
  - Nr.4/2021
  - Nr.3/2021
  - Nr.2/2021
  - Nr.1/2021
- 2020
  - Nr.4/2020
  - Nr.3/2020
  - Nr.2/2020
  - Nr.1/2020
  - Supplement 1/2020
- 2019
  - Nr.4/2019
  - Nr.3/2019
  - Nr.2/2019
  - Nr.1/2019
  - Supplement 1/2019
- 2018
  - Nr.4/2018
  - Nr.3/2018
  - Nr.2/2018
  - Nr.1/2018
  - Supplement 1/2018
  - Supplement 2/2018
  - Supplement 3/2018
- 2017
  - Nr.4/2017
  - Nr.3/2017
  - Nr.2/2017
  - Nr.1/2017
  - Supplement 1/2017
- 2016
  - Nr.4/2016
  - Nr.3/2016
  - Nr.2/2016
  - Nr.1/2016
  - Supplement 1/2016
- 2015
  - Nr.4/2015
  - Nr.3/2015
  - Nr.2/2015
  - Nr.1/2015
  - Supplement 1/2015
- 2014
  - Nr.4/2014
  - Nr.3/2014
  - Nr.2/2014
  - Nr.1/2014
  - Supplement 1/2014
- 2013
  - Nr.4/2013
  - Nr.3/2013
  - Nr.2/2013
  - Nr.1/2013
  - Supplement 1/2013
- 2012
  - Nr.4/2012
  - Nr.3/2012
  - Nr.2/2012
  - Nr.1/2012
  - Supplement 1/2012
- 2011
  - Nr.4/2011
  - Nr.3/2011
  - Nr.2/2011
  - Nr.1/2011
  - Supplement 1/2011
- 2010
  - Nr.4/2010
  - Nr.3/2010
  - Nr.2/2010
  - Nr.1/2010
  - Supplement 1/2010
- 2009
  - Nr.4/2009
  - Nr.3/2009
  - Nr.2/2009
  - Nr.1/2009
  - Supplement 1/2009
- 2008
  - Nr.4/2008
  - Nr.3/2008
  - Nr.2/2008
  - Nr.1/2008
  - Supplement 1/2008
- 2007
  - Nr.4/2007
  - Nr.3/2007
  - Nr.2/2007
  - Nr.1/2007
- 2006
  - Nr.4/2006
  - Nr.3/2006
  - Nr.2/2006
  - Nr.1/2006
- 2005
  - Nr.1/2005
Instructions for authors
Online applications
- Send an article
- Online payments
Editorial
About us
Links

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12

Top 10 downloaded articles - July 2025 -

Vitamin K and bone metabolism...	2
High Prevalence of CTX-M Group...	2
Sanger sequencing of MMR genes...	2
Molecular diagnostic of Ureapl...	2
Investigation of Apoptotic and...	2
Association of C5a/C5aR pathwa...	2
Normality assessment, few para...	2
High DNAJA4 expression correla...	2
Agreement between different eG...	2
Investigation of cytokine chan...	2

Concept, Design & Programming
Dr. Adrian Man

Nr. 33(2)/2025 DOI:10.2478/rrlm-2025-0014

Short communication

The EAS-EFLM consensus on the evaluation of atherogenic lipoproteins in the management of dyslipidemia: A synthesis of the recommendations

Ion Bogdan Mănescu, Krisztina Pál, Minodora Dobreanu

Correspondence should be addressed to: Ion Bogdan Mănescu

Abstract:

Given the essential role of the clinical laboratory in the diagnosis and monitoring of dyslipidemia, it is crucial that professionals in this field remain consistently informed about the relevant European and national guidelines and consensus documents. In this context, the European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) published, in 2020, a consensus statement on the quantification of atherogenic lipoproteins in the management of dyslipidemias. With the aim of disseminating this valuable information within the Romanian laboratory medicine community, we have prepared this paper as a synthesis in Romanian of the key recommendations from the aforementioned EAS/EFLM consensus. Following the structure of the original publication, the recommendations are organized according to the main phases of the testing process: pre-analytical, analytical, and post-analytical. It should be noted that the original document is significantly more comprehensive; in this work, we have limited ourselves to highlighting the main practical recommendations. For readers seeking a deeper understanding of the scientific rationale behind these guidelines, we encourage consulting the original publication.

Keywords: consens, dislipidemie, EAS/EFLM, management, recomandare

Received: 28.4.2025
Accepted: 29.4.2025
Published: 30.4.2025

Download full text PDF
(599 KB)

Mănescu IB, Pál K, Dobreanu M. The EAS-EFLM consensus on the evaluation of atherogenic lipoproteins in the management of dyslipidemia: A synthesis of the recommendations. Rev Romana Med Lab. 2025;33(2):111-8. DOI:10.2478/rrlm-2025-0014